these nuclear zones. 53BP1 foci were detected using a spot finding algorithm and values describing focus size and intensity were obtained. Data tables describing average and total scores of nuclear and 53BP1 focus attributes were compiled within Acapella and exported for visualization in standard graphing programs. The detailed script for focus detection is available upon request.
Assessment of z-scores for siRNAs
To score siRNAs during the primary screen according to their potency in affecting 53BP1 focus formation, we ranked each quadruplicate transfection according to their z-score, which allowed correcting for plate-to-plate variations. For each RNAi we derived a population mean X and standard deviation σ . To center X around the non-targeting control (ntc) we calculated an adjustment factor alpha = median(X_ntc)/sd(X_ntc) and used the non-targeting control as follows:
where μ = is the median non-targeting control between wells per plate and σ = the standard deviation of the sample population of X.
Time-lapse microscopy
Three-dimensional image datasets were acquired on a DeltaVision Core imaging system equipped with an Olympus IX71 microscope, a CoolSNAP HQ2 1024x1024 CCD camera (Roper Scientific), and a 60X NA 1.42 using 2x2 binning. Z-stacks were acquired every 5 minutes, computationally deconvolved using the SoftwoRx software package (v3.6, Applied Precision) and shown as two-dimensional projections.
Antibodies and immunoblotting
Whole-cell extracts, immunoblotting and immunoprecipitation was carried out essentially as described in (3). We employed the following antibodies: rabbit anti-RNF8 antibody specific to human RNF8 (4, 5), mouse anti-53BP1 (clone 19, BD Biosciences), mouse anti-MDC1 (clone MDC1-50, Sigma-Aldrich), goat anti-MDC1 (AbD, Serotec), sheep anti-MDC1 (6), mouse anti-γ-H2AX (clone JBW301, Upstate), rabbit anti-γH2AX (Cell Signaling Technologies), rabbit anti-FANCD2 (Novus Biologicals), mouse anti-BRCA1 (clone MS110, Calbiochem; clone D9, Santa Cruz), rabbit anti-RAP80 (Bethyl Laboratories), mouse anti-histone H3 phosphoserine 10 (clone 6G3, Cell Signaling Technologies), mouse anti-poly-ubiquitin (clone FK2, Stressgen). 1), mouse anti-GST (clone B4, Santa Cruz), mouse anti-ATM (clone mat3, a gift from Y. Shiloh), rabbit antiNbs1/p95 (Novus Biologicals), rabbit anti-53BP1 (Novus Biologicals), rabbit anti-Chk2 pT68 (Calbiochem), goat anti-Chk2 (Santa Cruz), rabbit anti-SMC1 and anti-SMC1 pS966 (Bethyl). The MDC1 pT719 antiserum was raised and affinity-purified against a phospho-peptide encoding MDC1 amino acid residues 713-725 by Abcam Plc (Cambridge, UK) and an additional rabbit anti-RNF8 antibody was raised against recombinant RNF8 (amino acid residues 343-485).
ATM kinase assays
serum was added to 500 μg of HeLa nuclear extracts (www.cilbiotech.be) in an equal volume of IP buffer (25 mM HEPES pH 7.4, 2 mM MgCl 2 , 25 0mM KCl, 10% glycerol, 0.5 mM EGTA, 0.1 mM NaVO 4 , 0.1% M NP-40) and incubated at 4 o C for 2 hrs.
Immune complexes were subsequently isolated with protein G sepharose (Sigma- 
Recombinant protein production
Expression of recombinant protein in E. coli strain BL21(DE3) pLysS was induced at o C when bacterial cultures reached OD 600 of 0.8 using 1 mM 1-β-Dthiogalactopyranoside. Fusion proteins were usually purified on glutathione-Sepharose 4B according to the batch method described in the GST manual (Pharmacia).
Surface Plasmon resonance
For surface plasmon resonance, biotinylated peptides were immobilized on a streptavidin-coated chip (SA5) using a BIAcore 3000 (GE Healthcare). Biotinylated peptide (0.1 mM) was manually injected at 10 μL/min to an equivalent of 400 resonance units (RU). The GST-FHA fusions were injected at a flow rate of 10 μL/min. To regenerate the surface after each sample, 10 mL of 0.5% SDS in 50 mM Tris-Cl, pH 7.4, 150 mM NaCl, 0.3% NP-40, 1 mM DTT, 1 mM PMSF were injected. This proved sufficient to dissociate completely the FHA-peptide complex without affecting the streptavidin-peptide complex. The temperature was maintained at 4°C for the duration of the experiment.
Immunofluorescence microscopy
HeLa or U2OS cells were grown on glass coverslips. Cells were washed with PBS twice before fixation. 
Peptide pull-downs
Peptide pull-downs were carried out by mixing 1 mg of HeLa nuclear extracts and 30 μL streptavidin Dynabeads (Dynal) saturated with the following biotinylated peptides. All incubations and washes were carried out in the following buffer: 150 mM NaCl, 3 mM KCl, 25 mM Tris pH 8.0, 10% glycerol, 1 mM DTT, 1 X protease inhibitors (complete tablets, mini EDTA-free, Roche).
Clonogenic survival assays.
HeLa cells in 100 mm dishes were transfected twice with control, ATM and RNF8 siRNAs at 24 hour time intervals. 24 hrs after the second transfection, cells were split and transferred into 60 mm dishes for irradiation 12 hrs later. The clonogenic assay was set up exactly as in (7). Cells were irradiated using a Faxitron X-ray cabinet at 3.125
Gy/min dose rate, at various doses, and immediately transferred into 6-well dishes. 14 days after irradiation cells were washed with PBS, fixed and stained with a mix of 20% methanol/0.5% Crystal Violet. Colonies containing 50 or more cells were counted using a stereo-dissecting microscope.
G2/M checkpoint analysis
U2OS cells were exposed to 2 Gy IR 48 hrs after siRNA transfection. Cells were harvested 1 hr after IR. Cells were washed with PBS twice and then fixed with 1% U20S cells. Cells were fixed 1 hr post irradiation and processed for imaging on the Opera microscope as described in Fig. 2A . The box-plot graph is represents the data acquired on 16 wells. An unpaired t-test was calculated to assess the significance of the difference between the control esiRNA and the esiRNA against UBC13. 
